Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment

Scott A Hundahl, John S. Macdonald, Jacqueline Benedetti, Thomas Fitzsimmons

Research output: Contribution to journalArticle

205 Citations (Scopus)

Abstract

Background: Intergroup 0116 (Southwest Oncology Group 9008), a national, multicenter, two-armed, prospective, randomized trial of adjuvant postoperative chemoradiotherapy, has demonstrated significant benefit. Methods: We prospectively captured complete surgical information, including the treatment of various lymph node stations, for 553 of the 556 eligible participants in this trial. Before any survival analysis, we coded D level by using the Japanese general rules and used the Maruyama program to estimate the likelihood of disease in undissected regional node stations, defining the sum of these estimates as the Maruyama Index of Unresected Disease (MI). We analyzed survival with Cox multivariate regression. Results: Fifty-four percent of participating patients underwent D0 lymphadenectomy. The median MI was 70 (range, 0-429). In contrast to D level, MI proved to be an independent prognostic factor, even with adjustment for the potentially linked variables of T stage and number of positive nodes. We detected no significant interaction between surgical or pathologic variables and the favorable effect of adjuvant treatment, but the power to detect such interaction was generally low. Conclusions: MI, a measure of unresected regional nodal disease in gastric cancer, proved an independent predictor of survival. Surgical undertreatment, as observed in this trial, clearly undermined survival.

Original languageEnglish (US)
Pages (from-to)278-286
Number of pages9
JournalAnnals of Surgical Oncology
Volume9
Issue number3
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Chemoradiotherapy
Stomach Neoplasms
Survival
Adjuvant Chemoradiotherapy
Survival Analysis
Lymph Node Excision
Therapeutics
Lymph Nodes

Keywords

  • Gastric cancer
  • Lymphadenectomy
  • Quality
  • Stomach cancer
  • Surgery
  • Survival

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer : The effect of undertreatment. / Hundahl, Scott A; Macdonald, John S.; Benedetti, Jacqueline; Fitzsimmons, Thomas.

In: Annals of Surgical Oncology, Vol. 9, No. 3, 2002, p. 278-286.

Research output: Contribution to journalArticle

@article{84567a47a255419883d6be7ec9754289,
title = "Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment",
abstract = "Background: Intergroup 0116 (Southwest Oncology Group 9008), a national, multicenter, two-armed, prospective, randomized trial of adjuvant postoperative chemoradiotherapy, has demonstrated significant benefit. Methods: We prospectively captured complete surgical information, including the treatment of various lymph node stations, for 553 of the 556 eligible participants in this trial. Before any survival analysis, we coded D level by using the Japanese general rules and used the Maruyama program to estimate the likelihood of disease in undissected regional node stations, defining the sum of these estimates as the Maruyama Index of Unresected Disease (MI). We analyzed survival with Cox multivariate regression. Results: Fifty-four percent of participating patients underwent D0 lymphadenectomy. The median MI was 70 (range, 0-429). In contrast to D level, MI proved to be an independent prognostic factor, even with adjustment for the potentially linked variables of T stage and number of positive nodes. We detected no significant interaction between surgical or pathologic variables and the favorable effect of adjuvant treatment, but the power to detect such interaction was generally low. Conclusions: MI, a measure of unresected regional nodal disease in gastric cancer, proved an independent predictor of survival. Surgical undertreatment, as observed in this trial, clearly undermined survival.",
keywords = "Gastric cancer, Lymphadenectomy, Quality, Stomach cancer, Surgery, Survival",
author = "Hundahl, {Scott A} and Macdonald, {John S.} and Jacqueline Benedetti and Thomas Fitzsimmons",
year = "2002",
doi = "10.1245/aso.2002.9.3.278",
language = "English (US)",
volume = "9",
pages = "278--286",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer

T2 - The effect of undertreatment

AU - Hundahl, Scott A

AU - Macdonald, John S.

AU - Benedetti, Jacqueline

AU - Fitzsimmons, Thomas

PY - 2002

Y1 - 2002

N2 - Background: Intergroup 0116 (Southwest Oncology Group 9008), a national, multicenter, two-armed, prospective, randomized trial of adjuvant postoperative chemoradiotherapy, has demonstrated significant benefit. Methods: We prospectively captured complete surgical information, including the treatment of various lymph node stations, for 553 of the 556 eligible participants in this trial. Before any survival analysis, we coded D level by using the Japanese general rules and used the Maruyama program to estimate the likelihood of disease in undissected regional node stations, defining the sum of these estimates as the Maruyama Index of Unresected Disease (MI). We analyzed survival with Cox multivariate regression. Results: Fifty-four percent of participating patients underwent D0 lymphadenectomy. The median MI was 70 (range, 0-429). In contrast to D level, MI proved to be an independent prognostic factor, even with adjustment for the potentially linked variables of T stage and number of positive nodes. We detected no significant interaction between surgical or pathologic variables and the favorable effect of adjuvant treatment, but the power to detect such interaction was generally low. Conclusions: MI, a measure of unresected regional nodal disease in gastric cancer, proved an independent predictor of survival. Surgical undertreatment, as observed in this trial, clearly undermined survival.

AB - Background: Intergroup 0116 (Southwest Oncology Group 9008), a national, multicenter, two-armed, prospective, randomized trial of adjuvant postoperative chemoradiotherapy, has demonstrated significant benefit. Methods: We prospectively captured complete surgical information, including the treatment of various lymph node stations, for 553 of the 556 eligible participants in this trial. Before any survival analysis, we coded D level by using the Japanese general rules and used the Maruyama program to estimate the likelihood of disease in undissected regional node stations, defining the sum of these estimates as the Maruyama Index of Unresected Disease (MI). We analyzed survival with Cox multivariate regression. Results: Fifty-four percent of participating patients underwent D0 lymphadenectomy. The median MI was 70 (range, 0-429). In contrast to D level, MI proved to be an independent prognostic factor, even with adjustment for the potentially linked variables of T stage and number of positive nodes. We detected no significant interaction between surgical or pathologic variables and the favorable effect of adjuvant treatment, but the power to detect such interaction was generally low. Conclusions: MI, a measure of unresected regional nodal disease in gastric cancer, proved an independent predictor of survival. Surgical undertreatment, as observed in this trial, clearly undermined survival.

KW - Gastric cancer

KW - Lymphadenectomy

KW - Quality

KW - Stomach cancer

KW - Surgery

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0036217320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036217320&partnerID=8YFLogxK

U2 - 10.1245/aso.2002.9.3.278

DO - 10.1245/aso.2002.9.3.278

M3 - Article

C2 - 11923135

AN - SCOPUS:0036217320

VL - 9

SP - 278

EP - 286

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 3

ER -